Vaccination with Theratope (STn-KLH) as treatment for breast cancer (Q35987797)

11 August 2017

1 reference

title

Vaccination with Theratope (STn-KLH) as treatment for breast cancer (English)

1 reference

11 August 2017

1 reference

2

Brenda M Sandmaier

1 reference

11 August 2017

Leona A Holmberg

1

1 reference

11 August 2017

publication date

1 December 2004

1 reference

Expert Review of Vaccines

11 August 2017

published in

1 reference

11 August 2017

volume

3

1 reference

11 August 2017

issue

6

1 reference

11 August 2017

page(s)

655-663

1 reference

Antitumor Activity and Immune Responses Induced by a Recombinant Carcinoembryonic Antigen-Vaccinia Virus Vaccine

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.6.655

Generation of human cytotoxic T cells specific for human carcinoembryonic antigen epitopes from patients immunized with recombinant vaccinia-CEA vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.6.655

Sialosyl-Tn. A novel mucin antigen associated with prognosis in colorectal cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.6.655

Expression of sialyl-Tn predicts the effect of adjuvant chemotherapy in node-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.6.655

Expression of sialyl-Tn in gastric cancer: correlation with known prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.6.655

Generation and decay of the immune response to a progressive fibrosarcoma. I. Ly-1+2- suppressor T cells down-regulate the generation of Ly-1-2+ effector T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.6.655

Concomitant Presence of Tumor-Specific Cytotoxic and Inhibitor Lymphocytes in Patients with Osteogenic Sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.6.655

A randomised phase II study of sialyl-Tn and DETOX-B adjuvant with or without cyclophosphamide pretreatment for the active specific immunotherapy of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.6.655

T cells as antigen-presenting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.6.655

T cell recognition of Tn-glycosylated peptide antigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.6.655

21 January 2018

Identifiers

DOI

10.1586/14760584.3.6.655

1 reference

11 August 2017

1 reference